Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Burlington › NPI 1437135886
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $15.65M by Medicaid between Jan 2018 and Dec 2024, across 400 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 10.0% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
BURLINGTON, NC 27215
33aNPI1437135886assigned 12/19/2005
33bProvider typeClinical Medical Laboratory
28Total paid$15.65M
24GClaims2,122,117
24DCodes billed400
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in North Carolina

Rank by total paid#13 of 128
Median peer was paid$268K
This provider vs. median58×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018416,978$8.31M
2019406,000$2.93M
2020407,361$3.83M
2021411,165$124K
2022454,091$152K
202318,974$138K
2024incomplete7,548$154K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 10.0% 44,990 33,187 $1.56M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.1% 66,303 64,348 $951K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 6.0% 65,924 63,978 $942K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 5.8% 10,014 7,933 $905K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 5.4% 6,746 5,885 $838K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.7% 55,581 55,075 $584K
80053 Comprehensive metabolic panel 3.6% 137,848 130,215 $565K
84443 Thyroid stimulating hormone (TSH) 3.4% 81,784 80,182 $534K
81374 2.9% 21,711 20,233 $461K
80061 Lipid panel 2.5% 74,843 74,285 $390K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 2.5% 2,026 1,990 $389K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.4% 124,015 115,584 $369K
388 more codes
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.5% 12,373 $229K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.4% 23,791 $219K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.4% 18,842 $213K
83036 Hemoglobin; glycosylated (A1C) 1.3% 56,885 $202K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.2% 15,989 $193K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.1% 13,333 $176K
84439 1.0% 44,769 $159K
36415 Collection of venous blood by venipuncture <1% 159,102 $144K
81377 <1% 4,053 $141K
82607 <1% 25,888 $135K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 10,471 $130K
80321 <1% 9,255 $130K
87086 Culture, bacterial; quantitative colony count, urine <1% 38,028 $125K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 11,292 $106K
82728 <1% 23,677 $104K
86803 <1% 21,154 $99K
87536 <1% 2,808 $93K
81381 <1% 4,431 $92K
85027 <1% 31,277 $89K
88142 <1% 11,819 $89K
86618 <1% 12,300 $76K
81383 <1% 2,357 $75K
87150 <1% 4,740 $73K
82746 <1% 13,262 $70K
84403 <1% 7,276 $68K
87340 <1% 14,645 $62K
80348 <1% 7,051 $62K
83655 <1% 12,514 $60K
84702 <1% 9,650 $59K
83550 <1% 19,790 $57K
86480 <1% 4,038 $57K
83970 <1% 3,836 $56K
86038 <1% 10,983 $54K
82652 <1% 3,522 $53K
86780 <1% 13,073 $52K
87481 <1% 1,066 $51K
80048 Basic metabolic panel (calcium, ionized) <1% 15,010 $51K
84153 <1% 7,284 $48K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,665 $44K
86360 <1% 2,592 $44K
86762 <1% 8,412 $43K
80074 <1% 2,459 $43K
87081 <1% 11,319 $42K
83540 <1% 19,335 $41K
86140 <1% 23,761 $40K
80346 <1% 2,349 $39K
87522 Neg quan hep c or qual rna <1% 1,781 $39K
83516 <1% 6,656 $39K
88141 <1% 3,463 $38K
86235 <1% 4,629 $37K
87510 <1% 5,260 $37K
87480 <1% 5,261 $37K
87660 <1% 5,259 $37K
84146 <1% 5,198 $36K
80364 <1% 1,656 $36K
80361 <1% 4,447 $36K
83735 <1% 14,238 $35K
81375 <1% 295 $35K
80365 <1% 4,404 $35K
82670 <1% 3,855 $35K
82105 <1% 4,662 $34K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 523 $34K
87070 <1% 7,640 $34K
87186 <1% 9,725 $34K
84481 <1% 5,076 $33K
84402 <1% 3,679 $33K
83001 <1% 5,002 $33K
88342 <1% 1,496 $32K
81401 <1% 333 $32K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 742 $30K
80353 <1% 4,035 $30K
80354 <1% 4,033 $29K
86696 <1% 3,711 $29K
84480 <1% 4,891 $28K
82784 <1% 8,610 $28K
83002 <1% 4,342 $28K
82043 <1% 12,417 $28K
87529 <1% 1,807 $28K
86850 <1% 10,549 $28K
80359 <1% 4,454 $28K
87077 <1% 9,093 $27K
86376 <1% 4,922 $26K
86665 <1% 3,767 $26K
80373 <1% 3,821 $25K
80372 <1% 3,792 $25K
87088 <1% 7,960 $25K
86200 <1% 5,045 $25K
81329 <1% 1,165 $25K
86359 <1% 1,734 $25K
84436 <1% 8,415 $25K
82570 <1% 13,013 $24K
85610 <1% 13,800 $24K
86225 <1% 4,780 $24K
81001 <1% 17,848 $23K
80324 <1% 3,778 $23K
86706 <1% 5,124 $23K
86800 <1% 4,200 $22K
86617 <1% 3,547 $21K
86787 <1% 4,817 $21K
86592 <1% 13,122 $20K
83021 <1% 2,012 $20K
80358 <1% 3,867 $20K
86255 <1% 2,986 $19K
80076 <1% 5,505 $19K
86664 <1% 2,913 $18K
83880 <1% 1,428 $17K
85652 <1% 17,827 $17K
83520 <1% 3,881 $17K
86765 <1% 3,859 $16K
86704 <1% 3,383 $16K
86431 <1% 7,515 $16K
82677 <1% 1,179 $16K
82550 <1% 5,233 $16K
81373 <1% 349 $15K
82533 <1% 2,466 $15K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 983 $15K
83690 <1% 5,709 $15K
84425 <1% 2,040 $15K
81003 <1% 12,705 $15K
86695 <1% 3,070 $14K
86160 <1% 3,058 $14K
88304 <1% 1,818 $14K
86663 <1% 1,926 $14K
86901 <1% 11,390 $14K
88307 <1% 180 $13K
84144 <1% 1,942 $13K
80164 <1% 1,742 $13K
86147 <1% 1,254 $12K
85730 <1% 5,428 $12K
85007 <1% 6,807 $12K
86900 <1% 10,525 $12K
84445 <1% 825 $12K
86336 <1% 1,379 $12K
82785 <1% 2,182 $12K
82627 <1% 1,527 $12K
84165 <1% 2,567 $12K
86141 <1% 2,001 $11K
86735 <1% 2,433 $11K
86708 <1% 2,075 $11K
87493 <1% 694 $11K
82947 <1% 5,754 $10K
88112 <1% 881 $10K
81025 <1% 2,747 $10K
84550 <1% 5,350 $9K
87209 <1% 1,426 $9K
80338 <1% 1,903 $9K
80334 <1% 1,903 $9K
82565 <1% 4,608 $9K
85651 <1% 5,013 $9K
83525 <1% 2,173 $9K
80178 <1% 2,255 $9K
83615 <1% 3,441 $8K
80362 <1% 1,755 $8K
82150 <1% 3,017 $8K
84100 <1% 4,560 $8K
84305 <1% 965 $8K
86709 <1% 1,684 $8K
80360 <1% 1,929 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 655 $8K
80050 General health panel <1% 475 $8K
80337 <1% 1,905 $8K
82977 <1% 2,738 $8K
80370 <1% 1,879 $8K
80368 <1% 2,082 $8K
86334 <1% 1,453 $8K
85246 <1% 925 $8K
86003 <1% 2,575 $8K
82164 <1% 1,297 $8K
82950 <1% 4,163 $8K
81479 Unlisted molecular pathology procedure <1% 41 $7K
84630 <1% 1,599 $7K
83992 <1% 2,112 $7K
87045 <1% 1,753 $7K
87255 <1% 339 $7K
87046 <1% 1,745 $7K
80369 <1% 371 $7K
82248 <1% 2,660 $7K
86705 <1% 1,254 $6K
86753 <1% 1,503 $6K
80347 <1% 2,939 $6K
86162 <1% 707 $6K
86666 <1% 1,446 $6K
80326 <1% 777 $6K
80367 <1% 803 $6K
80355 <1% 970 $6K
80331 <1% 767 $6K
84450 <1% 2,830 $6K
80371 <1% 793 $6K
82951 <1% 1,135 $6K
80366 <1% 1,014 $6K
86304 <1% 657 $6K
85245 <1% 546 $6K
83883 <1% 1,060 $6K
85240 <1% 864 $6K
84156 <1% 4,210 $5K
80069 <1% 1,715 $5K
84163 <1% 678 $5K
80357 <1% 1,655 $5K
84520 <1% 3,504 $5K
84703 <1% 1,895 $5K
87517 <1% 214 $5K
87177 <1% 1,597 $5K
83090 <1% 794 $5K
84460 <1% 2,064 $5K
84134 <1% 829 $5K
87427 <1% 1,164 $5K
82247 <1% 2,353 $5K
84484 <1% 1,156 $5K
82024 <1% 457 $5K
84155 <1% 3,406 $5K
80197 <1% 1,503 $5K
86146 <1% 738 $5K
84075 <1% 2,377 $5K
80349 <1% 775 $5K
87075 <1% 1,307 $5K
82040 <1% 2,384 $5K
87338 <1% 1,140 $5K
80344 <1% 767 $4K
87205 <1% 2,296 $4K
86039 <1% 948 $4K
85660 <1% 1,351 $4K
83498 <1% 512 $4K
87147 <1% 1,174 $4K
36416 <1% 3,093 $4K
83993 <1% 1,263 $4K
85018 <1% 3,126 $4K
87902 <1% 12 $4K
83921 <1% 765 $3K
80320 <1% 284 $3K
80341 <1% 774 $3K
84479 <1% 1,482 $3K
86677 <1% 522 $3K
85014 <1% 3,126 $3K
87329 <1% 712 $3K
84270 <1% 521 $3K
82310 <1% 1,901 $3K
86308 <1% 1,070 $3K
85046 <1% 1,529 $3K
82274 <1% 627 $3K
80051 <1% 980 $3K
82140 <1% 231 $3K
85613 <1% 749 $3K
87040 <1% 393 $3K
88341 <1% 146 $2K
86256 <1% 431 $2K
86707 <1% 425 $2K
87350 <1% 487 $2K
86430 <1% 886 $2K
84432 <1% 450 $2K
80159 <1% 120 $2K
82397 <1% 878 $2K
86060 <1% 741 $2K
84478 <1% 1,042 $2K
88262 <1% 12 $2K
87109 <1% 308 $2K
86364 <1% 1,628 $2K
82330 <1% 464 $2K
87101 <1% 420 $2K
82465 <1% 1,208 $2K
82525 <1% 618 $2K
85379 <1% 556 $2K
84295 <1% 1,171 $2K
86694 <1% 225 $2K
80377 <1% 1,930 $2K
83519 <1% 329 $2K
87563 <1% 1,045 $2K
84590 <1% 584 $2K
82435 <1% 1,098 $2K
83010 <1% 181 $2K
83789 <1% 71 $1K
86701 <1% 131 $1K
86317 <1% 440 $1K
81376 <1% 52 $1K
84681 <1% 501 $1K
84132 <1% 830 $1K
82085 <1% 270 $1K
81243 <1% 179 $1K
87176 <1% 305 $1K
87254 <1% 52 $1K
87071 <1% 141 $1K
82378 <1% 249 $1K
86258 <1% 619 $1K
84311 <1% 120 $1K
85732 <1% 520 $1K
82390 <1% 292 $1K
86645 <1% 121 $1K
82952 <1% 613 $1K
81241 <1% 117 $1K
88106 <1% 28 $986.37
85045 <1% 722 $970.18
82103 <1% 190 $932.97
88312 <1% 387 $860.86
87328 <1% 88 $835.70
82042 <1% 175 $835.70
86747 <1% 176 $803.58
87206 <1% 550 $785.19
86644 <1% 138 $779.02
86231 <1% 605 $739.88
85048 <1% 578 $719.02
83986 <1% 155 $544.34
80356 <1% 20 $530.80
84207 <1% 318 $475.25
86300 <1% 162 $456.80
84255 <1% 65 $409.76
87207 <1% 107 $393.98
84154 <1% 345 $382.13
82747 <1% 272 $346.36
86812 <1% 12 $344.04
83605 <1% 91 $320.89
80339 <1% 24 $296.02
81291 <1% 54 $266.40
87899 <1% 15 $241.05
82374 <1% 270 $212.46
81015 <1% 304 $179.18
86611 <1% 15 $163.28
80165 <1% 13 $161.24
86161 <1% 12 $148.10
81050 <1% 89 $143.01
80183 <1% 38 $130.85
87641 <1% 51 $129.99
88184 <1% 12 $128.22
85670 <1% 348 $114.43
82672 <1% 124 $96.26
86593 <1% 41 $93.66
84446 <1% 36 $92.67
85004 <1% 20 $88.70
87015 <1% 106 $81.62
84482 <1% 25 $71.16
86037 <1% 175 $70.25
87276 <1% 36 $64.28
88313 <1% 110 $61.40
84466 <1% 138 $61.35
89051 <1% 59 $55.08
87275 <1% 36 $53.28
88185 <1% 12 $47.24
81002 <1% 38 $45.24
87625 <1% 239 $40.55
85041 <1% 113 $35.71
85306 <1% 12 $30.64
86381 <1% 43 $20.55
86341 <1% 63 $17.06
86215 <1% 13 $13.00
82668 <1% 13 $10.96
86015 <1% 42 $9.32
82232 <1% 44 $8.79
87581 0% 278 $0.00
87476 0% 53 $0.00
83704 0% 160 $0.00
87650 0% 105 $0.00
87486 0% 274 $0.00
83521 0% 130 $0.00
85397 0% 56 $0.00
82553 0% 55 $0.00
86357 0% 25 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 14 $0.00
87468 0% 14 $0.00
86335 0% 26 $0.00
81240 0% 25 $0.00
82626 0% 13 $0.00
82656 0% 14 $0.00
86301 0% 45 $0.00
80177 0% 56 $0.00
86226 0% 12 $0.00
80230 0% 12 $0.00
86355 0% 15 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 0% 433 $0.00
99199 Unlisted special service, procedure or report 0% 161 $0.00
87653 0% 315 $0.00
83020 0% 786 $0.00
89055 0% 140 $0.00
80323 0% 742 $0.00
87799 0% 29 $0.00
83835 0% 26 $0.00
82542 0% 44 $0.00
87324 0% 13 $0.00
84166 0% 65 $0.00
82239 0% 14 $0.00
83721 0% 89 $0.00
85055 0% 88 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 0% 406 $0.00
88173 0% 12 $0.00
85384 0% 51 $0.00
87420 0% 72 $0.00
81490 0% 19 $0.00
86008 0% 14 $0.00
80375 0% 49 $0.00
82088 0% 14 $0.00
87185 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.